3D Body Explorer for Oncology + Hematology
AppThis item doesn’t have any videos yet
Add New VideoMedical | Education
iOS
Introducing the 3D Body Explorer for Oncology + Hematology - Transform the way you communicate with patients using the latest in interactive 3D technology!
Developed by Novartis Oncology and powered by the BioDigital Human, 3D Body Explorer for Oncology + Hematology pairs explorable, realistic visuals with essential product information.
The app has been designed to use at the point of care, assisting patients in understanding a complex disease. Features include:
- Zoom, pan, rotate, and dissect 3D models of anatomy and pathology
- Explore and interact with molecular mechanisms of disease
- Draw and annotate directly on the model
- Save and email models to patients and colleagues
- Access to up-to-date Novartis Prescribing Information, Important Safety Information, co-pay cards and more
About Novartis
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
For more information, visit: hcp.novartis.com.
About BioDigital
BioDigital, the leading developer of state-of-the-art 3D visualization for health, developed the first cloud-based, virtual body, the BioDigital Human Platform. This interactive, scientifically accurate virtual body enables users to learn about anatomy, health conditions, and treatments in a visual format that resembles life itself - lowering the barriers for people to understand complex medicine. BioDigital’s team of software engineers, 3D modelers, and scientists continue to push the limits of what’s possible when applying 3D technology to healthcare.
For more information, visit: biodigital.com and follow us on Facebook and Twitter.
Related Items:
Published by | BioDigital, Inc. |
Developed by | BioDigital, Inc. |
Certificate | 12+ |
Languages | English |
Compatibility | iPad, iPhone, iPod |
Images And Data Courtesy Of: BioDigital, Inc..
This content (including text, images, videos and other media) is published and used in accordance
with Fair Use.
9-10 |
|
0.0% (0) | |
7-8 |
|
0.0% (0) | |
5-6 |
|
100.0% (1) | |
3-4 |
|
0.0% (0) | |
1-2 |
|
0.0% (0) |